carbamates has been researched along with Pulmonary Fibrosis in 1 studies
Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.
| Excerpt | Relevance | Reference |
|---|---|---|
| "These findings demonstrate that AM966 is a potent, selective, orally bioavailable LPA(1) receptor antagonist that may be beneficial in treating lung injury and fibrosis, as well as other diseases that are characterized by pathological inflammation, oedema and fibrosis." | 1.36 | A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model. ( Baccei, CS; Bundey, RA; Chapman, C; Correa, LD; Evans, JF; Fagan, P; Hutchinson, JH; Lorrain, DS; Parr, TA; Prasit, P; Prodanovich, PC; Santini, AM; Seiders, TJ; Stebbins, KJ; Swaney, JS, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Swaney, JS | 1 |
| Chapman, C | 1 |
| Correa, LD | 1 |
| Stebbins, KJ | 1 |
| Bundey, RA | 1 |
| Prodanovich, PC | 1 |
| Fagan, P | 1 |
| Baccei, CS | 1 |
| Santini, AM | 1 |
| Hutchinson, JH | 1 |
| Seiders, TJ | 1 |
| Parr, TA | 1 |
| Prasit, P | 1 |
| Evans, JF | 1 |
| Lorrain, DS | 1 |
1 other study available for carbamates and Pulmonary Fibrosis
| Article | Year |
|---|---|
A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model.
Topics: Administration, Oral; Animals; Bleomycin; Bronchoalveolar Lavage Fluid; Calcium; Carbamates; Cell Li | 2010 |